Primary biliary cirrhosis following lactobacillus vaccination for recurrent vaginitis

Journal of Hepatology

Volumn 49, Issue 3, 2008, Pages 466-473

  Bogdanos, Dimitrios ^a   Pusl, Thomas ^b   Rust, Christian ^b   Vergani, Diego ^a   Beuers, Ulrich ^b,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

AMA; Budesonide; Lactobacillus; Molecular mimicry; PBC; UDCA

Indexed keywords

2 OXOACID DEHYDROGENASE; LACTOBACILLUS VACCINE; PYRUVATE DEHYDROGENASE;

ADULT; ARTICLE; CASE REPORT; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SPECIFICITY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LACTOBACILLUS DELBRUECKII; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; VACCINATION; VAGINITIS;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; BACTERIAL VACCINES; FEMALE; HUMANS; LACTOBACILLUS; LIVER CIRRHOSIS, BILIARY; MITOCHONDRIA; RECURRENCE; VAGINOSIS, BACTERIAL;

EID: 48449098497     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.05.022     Document Type: Article

References (33)

1. Kaplan M.M., and Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 353 (2005) 1261-1273
2. Poupon R.E., Chretien Y., Chazouilleres O., Poupon R., and Chwalow J. Quality of life in patients with primary biliary cirrhosis. Hepatology 40 (2004) 489-494
3. Talwalkar J.A., and Lindor K.D. Primary biliary cirrhosis. Lancet 362 (2003) 53-61
4. Nishio A., Keeffe E.B., and Gershwin M.E. Immunopathogenesis of primary biliary cirrhosis. Semin Liver Dis 22 (2002) 291-302
5. Shimoda S., Nakamura M., Ishibashi H., Kawano A., Kamihira T., Sakamoto N., et al. Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis. Gastroenterology 124 (2003) 1915-1925
6. Gershwin M.E., and Mackay I.R. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 47 (2008) 737-745
7. Rieger R., Leung P.S., Jeddeloh M.R., Kurth M.J., Nantz M.H., Lam K.S., et al. Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun 27 (2006) 7-16
8. Amano K., Leung P.S., Rieger R., Quan C., Wang X., Marik J., et al. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 174 (2005) 5874-5883
9. Ala A., Stanca C.M., Bu-Ghanim M., Ahmado I., Branch A.D., Schiano T.D., et al. Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites. Hepatology 43 (2006) 525-531
10. Selmi C., Balkwill D.L., Invernizzi P., Ansari A.A., Coppel R.L., Podda M., et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 38 (2003) 1250-1257
11. Bogdanos D.P., Baum H., Okamoto M., Montalto P., Sharma U.C., Rigopoulou E.I., et al. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology 42 (2005) 458-465
12. Allina J., Hu B., Sullivan D.M., Fiel M.I., Thung S.N., Bronk S.F., et al. T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 27 (2006) 232-241
13. Leung P.S., Coppel R.L., and Gershwin M.E. Etiology of primary biliary cirrhosis: the search for the culprit. Semin Liver Dis 25 (2005) 327-336
14. Gershwin M.E., Selmi C., Worman H.J., Gold E.B., Watnik M., Utts J., et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 42 (2005) 1194-1202
15. Siboulet A. Vaccination against nonspecific bacterial vaginosis. Double-blind study of Gynatren. Gynakol Rundsch 31 (1991) 153-160
16. Beuers U., and Rust C. Overlap syndromes. Semin Liver Dis 25 (2005) 311-320
17. Vergani D., Alvarez F., Bianchi F.B., Cançado E.L., Mackay I.R., Manns M.P., et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group. J Hepatol 41 (2004) 677-683
18. Bogdanos D.P., Baum H., Gunsar F., Arioli D., Polymeros D., Ma Y., et al. Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. Scand J Gastroenterol 39 (2004) 981-987
19. Bogdanos D.P., Pares A., Baum H., Caballeria L., Rigopoulou E.I., Ma Y., et al. Disease-specific cross-reactivity between mimicking peptides of heat shock protein of mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. J Autoimmun 22 (2004) 353-362
20. Moteki S., Leung P.S., Coppel R.L., Dickson E.R., Kaplan M.M., Munoz S., et al. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 24 (1996) 97-103
21. Bogdanos D.P., Baum H., Sharma U.C., Grasso A., Ma Y., Burroughs A.K., et al. Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol 36 (2002) 14-21
22. Bogdanos D.P., Lenzi M., Okamoto M., Rigopoulou E.I., Muratori P., Ma Y., et al. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. Int J Immunopathol Pharmacol 17 (2004) 83-92
23. Rodda S.J., and Tribbick G. Antibody-defined epitope mapping using the multipin method of peptide synthesis. Methods 9 (1996) 473-481
24. Bogdanos D.P., Baum H., Grasso A., Okamoto M., Butler P., Ma Y., et al. Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol 40 (2004) 31-39
25. Kerkar N., Choudhuri K., Ma Y., Mahmoud A., Bogdanos D.P., Muratori L., et al. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol 170 (2003) 1481-1489
26. Gregorio G.V., Choudhuri K., Ma Y., Pensati P., Iorio R., Grant P., et al. Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin Exp Immunol 133 (2003) 404-413
27. Polymeros D., Bogdanos D.P., Day R., Arioli D., Vergani D., and Forbes A. Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?. Gastroenterology 131 (2006) 85-96
28. Quinn J., Diamond A.G., Palmer J.M., Bassendine M.F., James O.F., and Yeaman S.J. Lipoylated and unlipoylated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis: significance of lipoate attachment. Hepatology 18 (1993) 1384-1391
29. Jois J., Omagari K., Rowley M.J., Anderson J., and Mackay I.R. Enzyme inhibitory antibody to pyruvate dehydrogenase: diagnostic utility in primary biliary cirrhosis. Ann Clin Biochem 37 (2000) 67-73
30. Rodda S.J., and Tribbick G. Antibody-defined epitope mapping using the multipin method of peptide synthesis. Methods 9 (1996) 473-481
31. Matsumura S., Van De Water J., Leung P., Odin J.A., Yamamoto K., Gores G.J., et al. Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology 39 (2004) 1415-1422
32. Corpechot C., Carrat F., Poupon R., and Poupon R.E. Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. Gastroenterology 122 (2002) 652-658
33. Corpechot C., Carrat F., Bahr A., Chretien Y., Poupon R.E., and Poupon R. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 128 (2005) 297-303